Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Cytorex Biosciences completes cytotoxicity testing with Cytoreg

July 14, 2004

Inhibitors of receptor tyrosine kinases claimed by Array BioPharma

July 13, 2004

Novel insulin-like growth factor-I receptor kinase inhibitors against tumor growth

July 13, 2004

Enrollment begins in phase II Xcytrin study for metastatic renal cell carcinoma

July 13, 2004

Abbott plans Xinlay NDA filing later this year

July 13, 2004

Antagonists of antiapoptotic protein for the treatment of cancer

July 12, 2004

Bayer describes agents for hyperproliferative disorders

July 12, 2004

Silicon compounds for GnRH related disorders

July 12, 2004

Lorus expands Canadian prostate cancer study of GTI-2501 and docetaxel

July 12, 2004

Enrollment open at European sites in CoFactor phase II study

July 12, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...